Alnylam Pharmaceuticals
ALNY
#378
Rank
HK$471.15 B
Marketcap
HK$3,566
Share price
-1.55%
Change (1 day)
82.00%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend yield history for this company